Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., BENZARTI, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hernandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... MOUSSAY, E.*. (29 June 2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL. Blood, 141 (26), 3166 - 3183. doi:10.1182/blood.2022017839 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Green, A. C., Marttila, P., Kiweler, N., Chalkiadaki, C., Wiita, E., Cookson, V., Lesur, A., Eiden, K., Bernardin, F., Vallin, K. S. A., Borhade, S., Long, M., Ghahe, E. K., Jiménez-Alonso, J. J., Jemth, A.-S., Loseva, O., Mortusewicz, O., MEYERS, M., VIRY, E., ... MEISER, J. (April 2023). Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nature Metabolism, 5 (4), 642 - 659. doi:10.1038/s42255-023-00771-5 Peer Reviewed verified by ORBi |
FERNANDEZ BOTANA, I. C.* , Pagano, G.* , MOUSSAY, E.* , & PAGGETTI, J.*. (2023). Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia. Oncoimmunology, 12 (1), 2276490. doi:10.1080/2162402X.2023.2276490 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Gargiulo, E., Viry, E., Morande, P. E., Largeot, A., Gonder, S., Xian, F., Ioannou, N., BENZARTI, M., Borgmann, F. B. K., MITTELBRONN, M., DITTMAR, G., NAZAROV, P., MEISER, J., Stamatopoulos, B., Ramsay, A. G., MOUSSAY, E.* , & PAGGETTI, J.*. (2023). Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses. Blood Cancer Discovery, 4 (1), 54 - 77. doi:10.1158/2643-3230.BCD-22-0029 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
GONDER, S., Largeot, A., Gargiulo, E., Pierson, S., Fernandez Botana, I., Pagano, G., PAGGETTI, J., & MOUSSAY, E. (08 September 2021). The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia. Cancers, 13 (18), 4518. doi:10.3390/cancers13184518 Peer Reviewed verified by ORBi |
GONDER, S.* , Fernandez Botana, I.* , Wierz, M.* , Pagano, G., Gargiulo, E., Cosma, A., MOUSSAY, E., PAGGETTI, J., & Largeot, A. (2020). Method for the Analysis of the Tumor Microenvironment by Mass Cytometry: Application to Chronic Lymphocytic Leukemia. Frontiers in Immunology, 11, 578176. doi:10.3389/fimmu.2020.578176 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Wierz, M., Pierson, S., Guyonnet, L., VIRY, E., Lequeux, A., Oudin, A., NICLOU, S. P., OLLERT, M., BERCHEM, G. J. M. J., JANJI, B., Guérin, C., PAGGETTI, J., & MOUSSAY, E. (05 April 2018). Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood, 131 (14), 1617-1621. doi:10.1182/blood-2017-06-792267 Peer Reviewed verified by ORBi |